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A quantitative screen for metabolic enzyme 
structures reveals patterns of assembly across 
the yeast metabolic network
ABSTRACT Despite the proliferation of proteins that can form filaments or phase-separated 
condensates, it remains unclear how this behavior is distributed over biological networks. We 
have found that 60 of the 440 yeast metabolic enzymes robustly form structures, including 
10 that assemble within mitochondria. Additionally, the ability to assemble is enriched at 
branch points on several metabolic pathways. The assembly of enzymes at the first branch 
point in de novo purine biosynthesis is coordinated, hierarchical, and based on their position 
within the pathway, while the enzymes at the second branch point are recruited to RNA stress 
granules. Consistent with distinct classes of structures being deployed at different control 
points in a pathway, we find that the first enzyme in the pathway, PRPP synthetase, forms 
evolutionarily conserved filaments that are sequestered in the nucleus in higher eukaryotes. 
These findings provide a roadmap for identifying additional conserved features of metabolic 
regulation by condensates/filaments.
INTRODUCTION
One of the central problems of cell biology is how cells organize 
biochemical reactions in space and time. Traditionally, studies of this 
problem have focused on the compartmentalization of reactions 
within membrane compartments and organelles. Recently, however, 
there has been an increasing appreciation that the dynamic parti-
tioning of proteins into novel nonmembranous compartments can 
be used to regulate cytoplasmic processes such as signal transduc-
tion and RNA metabolism (Banani et al., 2017; Boeynaems et al., 
2018). While the interaction domains and biophysical principles that 
govern the assembly and disassembly of signaling microclusters 
and RNA granules are increasingly well understood (Ditlev et al., 
2018), it has remained unclear how this understanding might be 
deployed in other regulatory or biosynthetic networks.
Because many of the concepts, such as end-product inhibi-
tion, that we rely upon to understand how biological networks 
are regulated were first described in metabolism (Adelberg and 
Umbarger, 1953; Pardee and Yates, 1956; Gerhart and Pardee, 
1962; Srere, 1987), one might expect that the formation of 
nonmembranous compartments may also play a critical role in 
regulating metabolic networks. Unfortunately, while studies have 
identified an increasing number of metabolic enzymes that are 
capable of forming biomolecular condensates and/or filaments, 
the connections between these structures and enzyme regulation 
have only been defined for a limited number of cases. For in-
stance, end-product inhibition by CTP has been found to trigger 
polymerization of bacterial CTP synthetase in an inactive confor-
mation (Barry et al., 2014). Similarly, assembly of yeast glutamine 
synthetase results in its inactivation (Petrovska et al., 2014). Con-
versely, work on mammalian CTP synthetase, mammalian acetyl 
CoA carboxylase, and liver phosphofructokinase has found that 
enzyme polymerization and activation are intimately connected 
(Meredith and Lane, 1978; Beaty and Lane, 1983a,b; Lynch et al., 
2017; Webb et al., 2017). Thus, while metabolic enzyme filaments 
can be used to both activate and sequester enzymes, it remains 
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unclear how such regulation is deployed throughout the meta-
bolic network.
While the relationship between metabolites and higher-order 
enzyme assembly is best understood for metabolic enzyme 
filaments, it is clear that classes of metabolic enzymes can also form 
condensates that behave similarly to the phase-separated structures 
observed in RNA granules and signal transduction (Jang et al., 
2016; Banani et al., 2017; Jin et al., 2017). The fluid nature of these 
structures has also led to renewed interest in whether they could be 
used to facilitate substrate channeling by partitioning multiple 
enzymatic steps of a pathway into clusters (Srere, 1987). For in-
stance, hypoxic stress has been found to trigger the reorganization 
of glycolytic enzymes in yeast and Caenorhabditis elegans, suggest-
ing that clustering could enhance glycolytic activity in response to 
energy stress (Jang et al., 2016; Jin et al., 2017). Similarly, the 
enzymes in the mammalian de novo purine biosynthetic pathway 
condense into a single structure, the purinosome, in response to 
purine limitation, mTOR signaling, and mitochondrial dysfunction 
(An et al., 2008, 2010; French et al., 2016), but these results have 
been controversial due to their reliance on transient expression of 
fluorescently tagged proteins (Zhao et al., 2013, 2014). Together, 
these findings suggest that distinct metabolic stresses can trigger 
sets of metabolic enzymes to form condensates via phase separa-
tion that can facilitate pathway flux. However, the basis of this 
phase-separating behavior and whether the assembly of entire 
pathways into a common structure is a broadly deployed mecha-
nism for regulating metabolic networks remain open questions.
This lack of clarity is in spite of the fact that several biochemical 
and visual screens for proteins that form condensates and/or fila-
ments have been conducted in Saccharomyces cerevisiae in recent 
years (Narayanaswamy et al., 2009; Noree et al., 2010; Tkach et al., 
2012; Mazumder et al., 2013; O’Connell et al., 2014; Chong et al., 
2015; Shen et al., 2016). While these screens have greatly expanded 
the number of proteins that form structures, these studies have 
failed to identify any rules or principles that govern which metabolic 
enzymes can form condensates/filaments and which cannot. One 
possible reason for this failure is that the majority of visual screens 
have not quantitatively examined the frequency of structure forma-
tion across multiple growth conditions. Thus, enzymes that form 
structures in a small percentage of cells are on an equal footing with 
enzymes that robustly form structures in every cell, potentially com-
plicating any analysis. Similarly, the fact that biochemical screens for 
protein aggregation detect only partial overlap with visual screens 
suggests that these two methodologies might have different levels 
of sensitivity for condensate/filament formation (O’Connell et al., 
2014). Thus, a screen that surveyed a variety of physiologically rel-
evant growth conditions and measured the frequency of structure 
formation would provide a robust data set for understanding the 
relationship between pathway architecture and enzyme conden-
sate/filament formation.
Additionally, previous screens have not explored the relationship 
between enzyme assembly and the known compartmentalization of 
biochemical pathways into organelles, such as mitochondria. Given 
the importance of pathway compartmentalization in regulating 
metabolic flux, determining which compartmentalized enzymes 
form structures and whether they assemble inside or outside the 
compartment could reveal missed connections between pathway 
architecture and the ability of enzymes to form condensates/
filaments.
To address both of these issues, as well as to expand the reper-
toire of metabolic enzymes capable of forming structures, we mea-
sured the frequency at which all 440 proteins in the yeast green fluo-
rescent protein (GFP) strain collection with an annotated role in 
metabolism form condensates/filaments under three different 
growth conditions (log phase, postdiauxic shift, and stationary 
phase). This screen identified 60 proteins capable of forming con-
densates or filaments in more than 10% of cells under at least one 
growth condition. This expanded the list of enzymes known to form 
condensates by 20. Our screen also identified 10 mitochondrial en-
zymes that form condensates within mitochondria at regions of high 
metabolic activity. Interestingly, we also identified several pathways 
where condensate formation was largely restricted to branch points 
in the metabolic network, suggesting that condensate formation 
might regulate flux at decision points in a pathway. Consistent with 
this, we found that the assembly of enzymes at the first branch point 
in de novo purine biosynthesis is coordinated, hierarchical, and 
based on their position within the pathway, while the enzymes at the 
second branch point are recruited to RNA stress granules. We have 
also found that the first enzyme in the pathway, phosphoribosyl py-
rophosphate (PRPP) synthetase, forms evolutionarily conserved fila-
ments that are sequestered in the nucleus in higher eukaryotes, ar-
guing that while the ability to form structures may be conserved, the 
regulatory role of the structures may diverge. Together, these results 
provide a framework for understanding the variety of ways meta-
bolic enzyme condensates and filaments can be used to regulate 
cellular metabolism.
RESULTS
A systematic screen for metabolic enzymes that form 
intracellular structures
Several screens to date have identified metabolic enzymes that 
assemble into intracellular structures (Narayanaswamy et al., 2009; 
Noree et al., 2010; O’Connell et al., 2012, 2014; Tkach et al., 2012; 
Mazumder et al., 2013; Chong et al., 2015; French et al., 2016; 
Shen et al., 2016; Saad et al., 2017). However, many of these prior 
studies have focused on a single enzyme, pathway, or growth con-
dition and often have scored only the presence or absence of a 
structure in the population of cells. This has made it difficult to 
determine how many metabolic enzymes are capable of assembly, 
the diversity of growth conditions that trigger assembly, and 
whether assembly occurs broadly or is restricted to a subpopula-
tion of yeast cells.
The goal of our screen was to quantitatively assess the ability of 
all 440 metabolic enzymes to form structures under three different 
growth conditions: log phase, postdiauxic shift (1 d), and stationary 
phase (5 d; Figure 1A). Each of these growth conditions represents 
a distinct metabolic state. During log phase, yeast cells grow and 
divide rapidly by fermentation of glucose present in the medium. 
Upon glucose limitation, yeast enter the postdiauxic shift, where 
they grow slowly and use the ethanol they produced during log 
phase. After ethanol and other nutrients have been utilized, cell divi-
sion is dramatically reduced and cells enter the stationary phase 
(Werner-Washburne et al., 1993; Braun et al., 1996).
By systematically identifying all of the enzymes that were capa-
ble of forming either foci or filaments and the frequency at which 
the structures formed, we hoped to identify any underlying 
principles governing which enzymes are capable of forming intracel-
lular structures. Furthermore, because some GFP fusions cause 
aggregation in only a small percentage of cells, we included only 
enzymes that formed structures in more than 10% of cells in our 
analysis. By these criteria, our screen has identified 60 metabolic 
enzymes that formed structures in more than 10% of cells under at 
least one growth condition (Supplemental Table S1). Forty-seven of 
these metabolic enzymes formed focus-like structures, while 11 
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assembled into discrete filaments (Figure 1B). Of these 11, we have 
identified three novel filament-forming enzymes that have not been 
identified in previous screens: Bna5p, Prs3p, and Prs5p. While Bna5 
encodes for kynureninase, Prs3p and Prs5p are subunits of yeast 
PRPP synthetase. The remaining eight filament-forming enzymes 
were also identified in previous screens of the yeast GFP strain col-
lection: acetyl CoA carboxylase (Acc1p), asparagine synthetase 
(Asn1p, Asn2p), glycogen debranching enzyme (Gdb1p), glutamate 
synthase (Glt1p), GDP-mannose pyrophosphorylase (Psa1p), and 
CTP synthetase (Ura7p, Ura8p; Noree et al., 2010; Petrovska et al., 
2014; Shen et al., 2016). While all of these enzymes are capable of 
forming distinct filaments, as assayed by pairwise colocalization 
(Supplemental Figure 1), five pairs of these filaments exhibit partial 
colocalization: Asn1p/Prs5p, Bna5p/Prs5p, Glt1p/Prs5p, Ura7p/
Prs5p, and Gdb1p/Ura7p. This type of assembly is reminiscent of 
the stress-specific lateral assembly of CTP synthase filaments with 
IMP dehydrogenase filaments in mammalian cells (Carcamo et al., 
2011; Keppeke et al., 2015; Chang et al., 2018). Thus, in addition to 
identifying three novel filament-forming metabolic enzymes, our 
screen has also significantly increased the number of metabolic fila-
ments capable of lateral interactions, providing a new window into 
this type of filament interaction.
FIGURE 1: Screen of metabolic enzymes reveals 20 new proteins capable of assembly into foci or filaments. 
(A) Schematic for screening the yeast GFP collection to identify all metabolic enzymes with the ability to form structures. 
Each strain was grown to log phase, postdiauxic shift, and stationary phase in YPD and fixed in 4% formaldehyde at 
room temperature for 15 min. Cells were washed and resuspended in 1 M sorbitol before imaging. (B) Multiple growth 
conditions expand the list of metabolic enzymes forming assemblies. Representative images of metabolic enzymes 
capable of assembly into filaments or foci in more than 10% of cells. Enzyme names highlighted in yellow represent 
previously unknown metabolic enzymes forming assemblies. Images were taken from the culture condition with the 
highest degree of assembly.
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Analysis of our screen revealed four basic patterns of assembly: 
log phase–restricted, stationary phase–restricted, nutrient-limited 
(restricted to both saturation and stationary phase), and constitutive. 
About 80% of the enzymes assemble solely when nutrients are limit-
ing. The largest single category was enzymes that assembled during 
both saturation and stationary phase (26/59), followed closely by 
enzymes that assembled only in stationary phase (17/59). Thus, 
while nutrient limitation is a major trigger for assembly across all 
metabolic pathways, the type of nutrient limitation (postdiauxic shift 
vs. stationary) is a key determinant of whether a particular enzyme 
will assemble.
Identification of metabolic enzymes that form structures 
within mitochondria
Previous screens of the yeast GFP strain collection for novel 
intracellular structures have focused largely on the presence or 
absence of a structure. However, there has been no systematic 
assessment of whether these enzyme structures are associated 
with organelles or other structures in the cell. This is particularly 
problematic because the compartmentalization of several meta-
bolic pathways to mitochondria is a key organizing principle of 
metabolic biochemistry. Furthermore, the yeast metabolic enzyme 
Ald4p has recently been found to form structures within the 
mitochondria, suggesting that a subset of metabolic enzymes 
might be forming within other compartments (Misonou et al., 
2014; Noree, 2018). The fact that our screen identified 24 putative 
mitochondrial metabolic enzymes presented us with a unique op-
portunity to explore the extent of metabolic enzyme self-assembly 
within mitochondria. GFP yeast strains for each of the 24 hits from 
our screen with a mitochondrial annotation were stained with 
MitoTracker to determine whether the structures assembled inside 
or outside of mitochondria (Supplemental Table S1; Supplemental 
Figure 2). Ten of the enzymes formed discrete puncta within the 
mitochondria and had annotations where the sole localization re-
ported in the SGD was the mitochondria (Figure 2A; Supplemental 
Figure 2). The remaining fourteen metabolic enzymes formed 
structures outside the mitochondria and were not studied further 
(Supplemental Figure 2).
In the course of analyzing our MitoTracker staining, we noted 
that enzyme structures were often found at sites of high signal. 
Because MitoTracker import reflects mitochondrial activity, this 
suggested that these enzymes were concentrated at regions of 
high respiratory activity. To confirm this, we also examined the lo-
calization of 10 assembling mitochondrial enzymes with the dye 
tetramethylrhodamine ethyl ester (TMRE), which, similarly to 
MitoTracker, displays brighter fluorescence signal at sites of high 
respiratory activity (Crowley et al., 2016). All 10 of these enzymes 
showed structure formation in regions of elevated mitochondrial 
activity with both dyes (Supplemental Figures 2 and 3). These re-
sults argued either that these enzymes were concentrated at re-
gions of high respiratory activity or that enzymes accumulated at 
regions of high mitochondrial density. To distinguish between 
these two possibilities, we transformed a subset of our yeast GFP 
strains with a plasmid expressing dsRed fused to a mitochondrial 
targeting sequence. The distribution of these enzymes within the 
mitochondria was then examined under the growth conditions 
where foci formation is observed, either log phase (Ald4p) or post-
diauxic shift (Fum1p, Ilv1p, Ilv2p). Our analysis revealed that the 
location of metabolic enzyme structures within mitochondria was 
not correlated with sites of high mitochondrial density, suggesting 
that these enzymes might be accumulating at sites of high mito-
chondrial activity (Figure 2B).
One potential location for these structures is the nucleoid, which 
has long been known to be associated with metabolic enzymes 
(Zelenaya-Troitskaya et al., 1995; Chen et al., 2007). However, the 
number of structures that we observe is not consistent with the 
typical numbers of nucleoids present within the mitochondrial 
network under these growth conditions (Miyakawa et al., 1984; 
Miyakawa, 2017). Furthermore, when we compared the results from 
our screen with proteomic analysis of the nucleoids from yeast, we 
found that only three of the 10 metabolic enzymes that copurified 
with nucleoids and were present in the GFP strain collection formed 
visible structures in our assay conditions (Miyakawa, 2017; Supple-
mental Figure 4). Thus, these enzymes are likely forming novel 
structures within mitochondria.
Enzymes that act at nodes in the purine biosynthetic 
pathway assemble into distinct visible intracellular 
structures
The fact that our screen uncovered interactions between different 
metabolic filaments and identified enzymes that assemble within 
mitochondria suggested that there might be levels of metabolic 
enzyme organization and coordination that have been missed in 
previous screens. To address this, we focused on one well-studied 
pathway, de novo purine biosynthesis, to determine whether there 
was any pattern to which enzymes formed structures and whether 
the pattern of assembly was coordinated with pathway activity/
regulation. We chose to use the de novo purine biosynthesis pathway 
for two reasons. First, studies of the de novo purine biosynthetic 
pathway in mammals have identified a subset of enzymes assembled 
into a common structure in response to purine deprivation, the puri-
nosome (Figure 3A; An et al., 2008). Second, while multiple purine 
biosynthetic enzymes in yeast have been found to form enzyme 
structures, the fact that these structures did not form a classic 
“purinosome” suggested that another form of regulation might be 
operating in S. cerevisiae (Narayanaswamy et al., 2009; O’Connell 
et al., 2014). Thus, a more in-depth analysis of this pathway in S. 
cerevisiae would allow us both to determine what aspects of enzyme 
organization, if any, are evolutionarily conserved and how assembly 
might be used to regulate metabolic flux through a pathway.
As part of this analysis, we rescreened all 21 proteins that com-
pose the de novo purine biosynthetic pathway for the ability to as-
semble into intracellular structures, the frequency with which these 
structures form, and the growth conditions that triggered assembly, 
using the yeast GFP strain collection. For each enzyme, the percent-
age of cells with GFP-labeled structures was determined in triplicate 
for four different growth conditions: log phase growth and cultures 
grown to 1 d (postdiauxic shift), 3 d (transitional), or 5 d (stationary 
phase). Our quantitative analysis found that 12 of the 21 proteins 
involved in de novo purine biosynthesis displayed little if any assem-
bly behavior (i.e., structures in <6% of cells under at least one growth 
condition; Figure 3, B–D; Supplemental Table S2). This list included 
Ade5,7p and Ade2p, which previous screens identified as forming 
foci (Narayanaswamy et al., 2009; O’Connell et al., 2014), but which 
form foci only at low frequency under our growth conditions (4.95% 
Ade5,7p; 2.98% Ade2p). In contrast, nine of the proteins showed a 
high level of assembly, with most forming structures in 30–80% of 
cells under at least one growth condition (Figure 3, B–D; Supple-
mental Table S2). These nine proteins that form structures repre-
sent five distinct purine biosynthetic enzymes: PRPP synthetase 
(Prs3p, Prs5p), PRPP amidotransferase (Ade4p), 5-amino-4-imidaz-
olecarboxamide ribonucleotide transformylase/IMP cyclohydrolase 
(Ade16/17p), adenylosuccinate synthase (Ade12p), and inosine 
monophosphate (IMP) dehydrogenase (Imd2-4p). Interestingly, four 
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of these five enzymes are known to be highly regulated by feedback 
inhibition and allosteric control, consistent with a role in flux control 
(Switzer and Sogin, 1973; Holmes et al., 1974; Van der Weyden and 
Kelly, 1974; Wyngaarden, 1976; Smith, 1998; Rebora et al., 2001). 
Additionally, all of these enzymes are found at branchpoints/nodes 
in the purine biosynthetic pathway. Furthermore, many enzymes 
that are recruited to the mammalian purinosome did not assemble 
to a significant degree in yeast. Using both HA and mNeonGreen 
fusions, we also confirmed that the assembly behavior of these nine 
proteins was not due to tag-specific dimerization or aggregation 
(Supplemental Figure 5). Additionally, the GFP tag did not cause 
auxotrophy in the cases where this could be examined (Supplemen-
tal Figure 5). Thus, these structures are not due to the GFP tag or 
protein denaturation.
The fact that these enzymes are assembling at branch points 
within a given pathway raised the question of whether or not this is 
a feature common to multiple metabolic pathways. Consistent with 
the de novo purine biosynthetic pathway, we found that enzymes 
that can form structures are found at highly connected portions of 
the glycolysis pathway, the glutamate biosynthetic pathway, and the 
methionine/cysteine biosynthetic pathway (Supplemental Figure 6). 
This suggests that spatial reorganization of metabolic enzymes 
might be used to coordinate flux through competing branches of 
particular pathways in response to nutrient limitation.
FIGURE 2: Metabolic enzymes can form discrete structures inside and/or outside of the mitochondria. (A) MitoTracker 
staining reveals differential distribution of metabolic enzyme structures inside or outside the mitochondria. Cells 
expressing GFP-tagged metabolic enzymes were incubated with 0.1 μM MitoTracker Red for 30 min. Cells were washed 
and then imaged immediately. (B) Assemblies of metabolic enzymes do not overlap with high-density regions of 
mitochondria. Cells expressing GFP-tagged metabolic enzymes were transformed with a plasmid containing a dsRed 
fluorescent protein attached to a mitochondrial targeting sequence (pVTU-mito-dsRED). Dual fluorescent strains were 
grown to either log phase (Ald4p) or postdiauxic shift (Fum1p, Ilv1p, Ilv2p) and imaged for colocalization.
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FIGURE 3: Enzymes in the de novo purine biosynthetic pathway assemble with different kinetics. (A) Schematic of 
the de novo purine biosynthetic pathway with yeast orthologues in blue on the left and mammalian orthologues in 
green on the right. Abbreviations for intermediate metabolites and catalytic enzymes: R5P = ribose-5-phosphate; 
PRPP = 5-phosphoribosylpyrophosphate; PRA = 5-phosphoribosylamine; GAR = 5-phosphoribosylglycineamide; FGAR = 
5′-phosphoribosyl- N-formylglycinamide; FGAM = 5′-phosphoribosyl-N-formylglycinamidine; AIR = 5′-phosphoribosyl-5-
aminoimidazole; CAIR = 5′- phosphoribosyl-4-carboxy-5-aminoimidazole; SAICAR = 5′-phosphoribosyl-4-(N-
succinocarboxamide)-5-aminoimidazole; AICAR = 5-amino-4-imidazolecarboxamide ribotide; FAICAR = 5-formamido-1-
(5-phosphoribosyl)-imidazole-4-carboxamide; IMP = inosine-5′-monophosphate; XMP = xanthosine-5′-phosphate; 
GMP = guanosine-5′-phosphate; GDP = guanosine-5′-diphosphate; SAMP = adenylosuccinate; AMP = adenosine-5′-
phosphate; ADP = adenosine-5′-diphosphate; Prs1-5p = phosphoribosylpyrophosphate synthetase; Ade4p = 
amidophosphoribosyltransferase; Ade5,7p = GAR synthetase/AIR synthetase; Ade8p = GAR transformylase; Ade6p = 
FGAM synthetase; Ade2p = AIR carboxylase; Ade1p = SAICAR synthase; Ade16/17p = IMP cyclohydrolase; Ade12p = 
adenylosuccinate synthetase; Ade13p = adenylosuccinate lyase; Adk2p = mitochondrial GTP:AMP phosphotransferase; 
Adk1p = adenylate kinase; Imd2-4p = IMP dehydrogenase; Gua1p = GMP synthetase; Guk1p = guanylate kinase; PPAT = 
PRPP amidotransferase; TrifGART = trifunctional glycinamide ribonucleotide (GAR) transformylase; GARS = GAR 
synthase; GAR Tfase = GAR transformylase; AIRS = aminoimidazole ribonucleotide (AIR) synthase; FGAMS = 
formylglycinamidine ribonucleotide (FGAM) synthase; PAIC = phosphoribosylaminoimidazole carboxylase; CAIRS = 
carboxyaminoimidazole ribonucleotide (CAIR) synthase; SAICARS = succinylaminoimidazolecarboxamide ribonucleotide 
(SAICAR) synthase; ASL = adenylosuccinate lyase; ATIC = AICAR transformylase/IMP cyclohydrolase; AICAR Tfase = 
aminoimidazolecarboxamide ribonucleotide (AICAR) transformylase; IMPCH = IMP cyclohydrolase. (B) Assembly of 
PRPP synthetase subunits is enriched for Prs3p and Prs5p. GFP-tagged versions of the PRPP synthetase proteins 
(Prs1p, Prs2p, Prs3p, Prs4p, Prs5p) were grown in YPD to log phase, 1-, 3-, and 5-d time points and assayed for 
assembly formation. Representative images are shown below. (C) Only enzymes located at branch points (Ade4p and 
Ade16/17p) assemble into foci. GFP-tagged versions of purine biosynthetic enzymes acting in the middle of the 
pathway were grown under conditions identical to those indicated in B and assayed for assembly formation. 
Representative images are shown below. (D) Ade12p is the only enzyme forming foci in the ADP production branch. 
GFP-tagged versions of purine biosynthetic enzymes involved in ADP production were grown under conditions identical 
to those indicated in B and assayed for assembly formation. Representative images are shown below. (E) All subunits of 
the IMPDH complex assemble into foci. GFP-tagged versions of purine biosynthetic enzymes involved in GDP 
production were grown under conditions identical to those indicated in B and assayed for assembly formation. 
Representative images are shown below. Data are represented as means of at least three independent experiments; 
error bars indicate SEM. Images were taken from the culture condition with the highest degree of assembly.
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Higher-order assembly is not used for substrate channeling 
or to coordinate activity at distinct nodes
Our finding that the only enzymes that form structures at high 
frequency are those that act at nodes in the de novo purine biosyn-
thetic pathway suggested three potential novel modes of regula-
tion. First, the enzymes at nodes could coassemble to route 
products down specific pathways via substrate channeling. Second, 
the enzymes that act at different nodes could coassemble to facili-
tate feedback inhibition. Third, pathway flux might not be regulated 
via coassembly of enzymes in this pathway. To distinguish between 
these possibilities, we performed pairwise colocalization experi-
ments between the enzymes that act at the first committed step in 
de novo purine biosynthesis (Prs3p, Prs5p, and Ade4p), as well as 
those that act at the second major branchpoint in the pathway, 
which are involved with generation and conversion of IMP into 
either GTP or ATP (Ade16p, Ade17p, Ade12p, and Imd4p). For 
each set of enzymes, one protein was tagged with GFP, while the 
second was tagged with mCherry (Figure 4). We observed colocal-
ization only when enzymes acted at the same step: Prs3p and 
Prs5p (Figure 4A), which are both subunits of PRPP synthetase, and 
Ade16p and Ade17p, which are isozymes of the bifunctional 
5- aminoimidazole-4-carboxamide ribonucleotide transformylase/
IMP cyclohydrolase (Figure 4B). These results argue that the assem-
bly of these enzymes into large structures is not a strategy for 
substrate channeling, since enzymes that act at different steps are 
not found in the same structure.
We next examined the possibility that enzymes acting at different 
nodes within the same or competing pathways might coassemble to 
facilitate coordinated regulation. First, we used pairwise colocaliza-
tion experiments to determine whether any enzymes acted at 
the first decision point in de novo purine biosynthesis that coas-
sembled with enzymes at the second decision point. Ade4p, which 
acts at the first committed step of de novo purine biosynthesis, 
showed no colocalization with any of the enzymes (Ade17p, 
Ade12p, and Imd4p) that act at the second decision point in the 
pathway (Figure 4C). Thus, the enzymes from the two major nodes 
of this pathway do not coassemble with each other. We also ex-
plored the possibility that enzymes that form intracellular structures 
and whose products are known to cross-regulate each other might 
coassemble to facilitate the balancing of flux through different parts 
of the metabolic network. Because the downstream products of 
Ade12p and Imd2/3/4p cross-regulate each other to ensure the bal-
anced synthesis of ATP and GTP, we tested whether these enzymes 
coassemble to facilitate pathway balancing. We observed no colo-
calization of these enzymes, arguing that the formation of these 
structures is not necessary for coordinating the activity of the 
different branches of the de novo purine biosynthetic pathway 
(Figure 4C). We also extended this analysis to coordination between 
FIGURE 4: Only intracellular structures formed by metabolic enzymes performing the same reaction colocalize with 
each other. (A) Prs5p does not colocalize with any downstream enzyme in the de novo purine biosynthetic pathway. 
Dual fluorescent strains were grown to 5 d in YPD for imaging. (B) Only Ade16p and Ade17p foci show colocalization 
with each other. Growth conditions were identical to those indicated in A. (C) Imd4p fails to colocalize with its upstream 
enzyme (Ade4p, Ade16p) or its cross-pathway enzyme (Ade12p). Growth conditions were identical to those indicated in 
A. (D) Unlike in other eukaryotes, IMP dehydrogenase (Imd2-4p) does not colocalize with CTP synthetase (Ura7p). 
Growth conditions were identical to those indicated in A.
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purine and pyrimidine biosynthesis. Because CTP synthetase (Ura7p) 
is a highly studied metabolic polymer and is allosterically activated 
by GTP, the downstream product of Imd2/3/4p, we examined 
whether Ura7p and Imd2/3/4p structures colocalized (Levitzki and 
Koshland, 1972; Ingerson-Mahar et al., 2010; Liu, 2010; Noree et al., 
2010; Carcamo et al., 2011). Ura7p filaments were not associated 
with any of the structures formed by Imd2p, Imd3, or Imd4p (Figure 
4D). Thus, while the ability of metabolic enzymes in the de novo 
purine biosynthetic pathway to form structures is restricted to those 
enzymes that act at key decision points in the pathway, there ap-
pears to be no coassembly to facilitate regulation within or between 
different pathways. This argues that the role of these enzyme struc-
tures in flux control does not occur via a substrate-channeling 
mechanism.
A subset of purine biosynthetic enzymes are components of 
RNA granules
Because the assembly of metabolic enzymes within the de novo 
purine biosynthetic pathway does not appear to be a mechanism 
for substrate channeling, we considered other ways these en-
zyme structures might impact metabolic flux. One way to control 
flux through a pathway is by modulating the levels of rate-limit-
ing enzymes in the cytoplasm (Jin et al., 2017; Saad et al., 2017). 
It was recently shown that yeast pyruvate kinase, Cdc19p, was 
recruited into RNA granules upon carbon starvation to regulate 
its enzymatic activity, highlighting a new localization pattern for 
controlling metabolic flux (Saad et al., 2017). Because many RNA 
granules form in the cytoplasm under the same conditions that 
cause metabolic enzymes to assemble, we examined the possi-
bility of any purine biosynthetic enzymes having similar cross-talk 
with these structures. To explore this possibility, we tested 
whether enzymes in purine biosynthesis form structures colocal-
ized with RNA stress granules (Ded1p-mCherry) and/or process-
ing bodies (Edc3p-mCherry). Prs3p and Prs5p were excluded 
from these studies because they form filaments that are clearly 
distinct from RNA granules. While Ade4p and Ade12p showed 
little (<5%) localization with either RNA granule marker when 
yeast is grown to stationary phase, the vast majority of Ade16p 
(91%) and Ade17p (90%) colocalized with the stress granule 
marker, Ded1p (Figure 5A; Supplemental Table S3). Furthermore, 
the remaining Ade16p (8%) and Ade17p (9%) structures appear 
to be processing bodies, as measured by colocalization with the 
processing body marker Edc3p-mCherry (Figure 5B; Supplemen-
tal Table S3). Thus, while stationary phase is a trigger for all four 
enzymes to assemble, only Ade16/17p is specifically recruited to 
RNA granules.
We also observed a higher degree of colocalization of Imd3p 
with stress granules than of Imd2p of Imd4p (Figure 5, A and B; 
Supplemental Table S3). The recruitment of one isoform of IMP 
dehydrogenase to stress granules suggests that Imd3p possesses a 
potential novel function in RNA metabolism, whereas the other 
isoforms do not. To further validate the presence of metabolic en-
zymes in stress granules, we assessed the degree of colocalization 
of Ade16p foci with two stress granule–associated chaperones, 
Hsp104p (69%) and Ssa1p (21%; Figure 5, C–E; Supplemental Table 
S4). Surprisingly, Ade16/17p and Imd3p also lack the prion-like/low-
complexity domains that typically play a role in recruitment of 
proteins to stress granules, suggesting that they are recruited via a 
novel mechanism (Protter and Parker, 2016). Thus, Ade16/17p and 
Imd3p are novel components of stress granules and their associa-
tion suggests a potential role in posttranscriptional gene regulation 
and metabolism.
Specific subunits of PRPP synthetase polymerize under 
distinct growth conditions
Because only a subset of purine enzymes are localized to RNA 
granules, we next explored other mechanisms for controlling path-
way activity, such as the sequestration of essential subunits into a 
structure. Yeast PRPP synthetase presents an excellent case study 
for such a possibility, due to its unusual subunit architecture. While 
PRPP synthetases in other organisms are homooligomeric, no single 
yeast Prs protein can form a functional enzyme and only certain 
heterooligomeric combinations of the five Prs proteins are enzymat-
ically active. Our initial screen identified two subunits (Prs3p and 
Prs5p) that were capable of filament formation and colocalized to 
the same structure (Figure 4A). Interestingly, all of the enzymatically 
active combinations of Prs subunits contain either Prs3p or Prs5p, 
but not both. Thus, these two subunits appear to delineate distinct 
forms of PRPP synthetase, a conclusion that is supported by the fact 
that PRS3Δ and PRS5Δ are synthetically lethal with each other 
(Hernando et al., 1998, 1999).
If selective polymerization of Prs3p and Prs5p is a mechanism for 
regulating PRPP synthetase activity, we would expect that the as-
sembly/disassembly of each subunit might be triggered by distinct 
growth conditions. To test this, we examined whether a brief 30-min 
shift into fresh medium could trigger the disassembly of Prs3p and/
or Prs5p filaments in yeast grown to stationary phase. This shift 
caused the rapid disassembly of both Prs3p and Prs5p filaments, 
while the protein levels of both proteins remained constant. Further-
more, 30-min shifts to YP alone caused no disassembly of Prs3p and 
Prs5p filaments (Figure 6A; Supplemental Table S5). As a result, we 
focused our attention on the role of glucose in triggering disassem-
bly of these filaments. Both Prs3p and Prs5p filaments disassemble 
in response to either the addition of fresh glucose to the culture or 
a 30-min shift to 2% glucose. Thus, the disassembly of both types of 
filaments is regulated by glucose.
Because addition of glucose triggers disassembly of Prs3p and 
Prs5p filaments, we predicted that removal of glucose from log-
phase cultures would trigger assembly. Interestingly, the assembly 
of Prs3p and Prs5p showed a differential response to glucose 
removal. While Prs3 and Prs5 do not show any structures during 
logarithmic growth, a 30-min shift to a medium lacking glucose was 
sufficient to trigger Prs5p filament formation in ∼90% of cells, but 
did not trigger Prs3p assembly (Figure 6B; Supplemental Table S6). 
Thus, two different subunits of PRPP synthetase in yeast, Prs5p and 
Prs3p, form filaments under distinct conditions: Prs3p assembles 
only in stationary phase, while Prs5p assembles in response to acute 
glucose limitation and stationary phase. Because glucose can 
directly generate the substrate for PRPP synthetase, ribose-
5-phosphate, via the pentose phosphate pathway (Zimmer, 1992), 
this result suggests that substrate availability could regulate polym-
erization of Prs3p and Prs5p.
Ade4p assembly is regulated by end-product inhibition
Given our results with PRPP synthetase, we next examined the 
disassembly behavior of the other purine biosynthetic enzymes 
that form structures. In all cases, a brief 30-min shift to fresh YPD 
caused elimination of all of the structures with no change in pro-
tein level (Figure 6A; Supplemental Figure 7). Additionally, shifting 
to YP had little or no effect on the disassembly of any of the purine 
biosynthetic structures (Figure 6A; Supplemental Figure 7; Supple-
mental Table S5). This suggested that glucose might regulate the 
disassembly of all of the structures in the de novo purine biosyn-
thetic pathway. The addition of fresh glucose to the culture or a 
30-min shift to 2% glucose caused Ade16/17p, Ade12p, and 
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FIGURE 5: Ade16p, Ade17p, and Imd3p are recruited into stress granules. (A) Ade16p, Ade17p, and Imd3p display 
high levels of colocalization with the stress granule marker Ded1p. Dual fluorescent strains were grown in YPD to 5 d, 
with the exception of Ade4p-GFP, which was examined at 1 d. (B) Enzymes in the purine biosynthetic pathway showed 
no colocalization with the processing body marker Edc3p. Growth conditions were identical to those indicated in A. 
(C) Ade16p colocalizes with the known stress granule–associated chaperone Hsp104p. Growth conditions were identical 
to those indicated in A. (D) Ade16p colocalizes with the known stress granule–associated chaperone Ssa1p. Growth 
conditions were identical to those indicated in A. (E) Quantification of colocalization of Ade16p with the chaperones 
Hsp104p and Ssa1p. Data are represented as means of at least three independent experiments; error bars 
indicate SEM.
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Imd2-4p structures to disassemble without a change in protein 
level (Supplemental Figure 7); however, Ade4p structures re-
mained intact (Figure 6; Supplemental Table S5). Additionally, we 
found that acute removal of glucose does not trigger the assembly 
of any purine biosynthetic enzyme other than Prs5p (Figure 6B). 
Thus, only Prs5p and Ade4p structures showed assembly/disas-
sembly behavior that was distinct from that of the other enzymes 
in the pathway.
FIGURE 6: Coordinated structure formation of Prs5p and Ade4p controls pathway flux. (A) Prs3p, Prs5p, and Ade4p 
structures disassemble in response to the presence of fresh glucose. Cells expressing GFP-tagged purine biosynthetic 
enzymes were grown in YPD for 5 d, except for the ADE4::GFP strain (1 d), and then shifted into the indicated media, 
incubated for 30 min at 30°C, and visualized immediately. Protein levels were determined by Western blot analysis and 
were normalized to no- treatment samples (indicated below blots). (B) Prs5p and Ade4p have distinct triggers for 
structure formation. Yeast cells expressing GFP-tagged purine biosynthetic enzymes were grown to log phase in 
complete SD media, shifted into the indicated media for 30 min at 30°C, and counted immediately. (C) Deletion of 
downstream enzymes of Ade4p leads to increased structure formation of Ade4p. Wild-type and mutant cells expressing 
Ade4p-GFP were grown in YPD for 1 d at 30°C and scored for structure formation. Protein levels were determined by 
Western blot analysis and were normalized to the wild-type strain (indicated below blots). (D) Loss of feedback inhibition 
increases focus formation by Ade4p. Cells expressing wild-type Ade4p-GFP and Ade4p(K333Q)-GFP were grown to log 
phase in YPD and cells were scored for frequency of structure formation. Protein levels were determined by Western 
blot analysis and were normalized to the wild-type strain (indicated below blots). Data are represented as means of at 
least three independent experiments; error bars indicate SEM. (E) Model for the coordinating activity of Prs5p and 
Ade4p with regulated structure assembly statuses is illustrated.
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Given this result, we focused our attention on whether acute re-
moval of adenine from the growth medium could trigger purine 
biosynthetic enzymes to assemble. We focused on the response to 
adenine limitation for two reasons. First, adenine removal would be 
predicted to increase flux though the de novo purine biosynthetic 
pathway. Thus, enzymes that assemble would be likely to be doing 
so in response to increased activity. Second, recent work on Ade4p 
suggested that removal of adenine for 2 h caused Ade4p to 
assemble into structures in a translation-dependent manner, raising 
the possibility that Ade4p structures form due to increased protein 
levels in response to adenine deprivation (Narayanaswamy et al., 
2009; O’Connell et al., 2014). To identify purine biosynthetic 
enzymes that formed adenine-responsive structures, strains were 
grown to log phase and then shifted to Ade– media for 30 min. Only 
Ade4p assembled (48% of cells), and no change in Ade4p protein 
levels was observed (Figure 6B; Supplemental Table S6). These 
results suggested that Ade4p formed structures in response to 
increased enzyme/pathway activity.
While adenine removal is a potent driver of Ade4p assembly, it 
was unclear what metabolic changes might be triggering the assem-
bly of Ade4p structures. Transcription of purine biosynthetic genes 
is known to increase in response to the elevated levels of the meta-
bolic intermediate 5-aminoimidazole-4-carboxamide ribonucleo-
tide (AICAR) that occur when flux through the pathway decreases 
(Pinson et al., 2009). To explore whether Ade4p assembly might be 
responding to changes in metabolite levels, we assayed the effect 
of deleting different enzymes in de novo purine biosynthesis on the 
assembly of Ade4p foci. Interestingly, Ade4p assembly differed 
from the transcriptional regulation of the ADE genes in that deletion 
of enzymes that act upstream of AICAR biosynthesis (ADE1 and 
ADE2), as well as of those that act downstream (ADE12), increased 
the number of Ade4p foci when cultures were grown to 1 d (Rebora 
et al., 2001; Pinson et al., 2009; Figure 6C). While all three deletions 
caused an increase in Ade4p foci as compared with wild type, the 
magnitude of the response differed between the different muta-
tions. Deletion of either ADE1 or ADE2 caused a 1.5-fold increase in 
Ade4p foci as compared with wild type, while deletion of ADE12, 
which acts downstream of IMP biosynthesis, caused a threefold in-
crease in Ade4p foci with almost all cells (93%) possessing Ade4p 
structures (Figure 6C; Supplemental Table S7). Notably, the increase 
in Ade4p focus formation occurred even though deletion of ADE1, 
ADE2, or ADE12 causes a decrease in Ade4p protein levels. The 
fact that disruption of either ATP and GTP synthesis (ade1Δ and 
ade2Δ) or solely ATP synthesis (ade12Δ) triggers an increase in 
Ade4p structures independent of expression levels suggested that 
decreases and/or imbalances in the amount of end products of the 
pathway regulate Ade4p assembly. Our epistasis analysis of Ade4p 
assembly is also consistent with the fact that Ade4p activity is regu-
lated by ATP and/or GTP levels via a feedback inhibition mechanism 
(Rebora et al., 2001).
To investigate whether Ade4p focus formation is responsive to 
feedback inhibition, we leveraged previous structural and biochemi-
cal studies of Escherichia coli amidophosphoribosyltransferase, the 
orthologue of Ade4p, which identified K326Q as a mutation that 
confers resistance to feedback inhibition without affecting enzyme 
activity (Zhou et al., 1993). To assess the role of feedback inhibition 
in Ade4p assembly, we introduced the equivalent mutation (K333Q) 
into the chromosomal ADE4 gene in yeast and measured the 
frequency of structure formation in log phase for Ade4p(K333Q)-
GFP as compared with wild-type cells. The Ade4p(K333Q)-GFP 
strain displayed a 2.6-fold increase in the percentage of cells with 
structures as compared with wild type, consistent with increased 
enzyme activity driving Ade4p assembly (Figure 6D; Supplemental 
Table S8). Thus, while Prs5p subunits are sequestered in an inactive 
filament, Ade4p assembles under conditions that either decrease 
end-product inhibition or necessitate increased pathway flux.
The assembly of Ade4p and Prs5p is coordinately regulated
If the ability of metabolic enzymes to assemble into filaments and 
foci is a mechanism for controlling pathway flux, one would expect 
that assembly/disassembly of different enzymes in the same path-
way would be highly coordinated. Consistent with this, we have 
found that acute glucose removal triggers down-regulation of PRPP 
synthetase activity via Prs5p sequestration, but does not cause acti-
vation of Ade4p and the assembly of Ade4p into structures (Figure 
6, A and B). Interestingly, the converse is also true—acute adenine 
removal causes activation of Ade4p and the formation of Ade4p 
structures, but does not cause the inactivation of PRPP synthetase 
by Prs5p polymerization (Figure 6B). While these observations are 
consistent with coordinated regulation of enzyme assembly, regula-
tion of assembly via glucose and adenine could be occurring inde-
pendent of each other. If Prs5p polymerization and Ade4p assembly 
were truly coordinately regulated, one would predict that removal of 
both glucose and adenine would cause Prs5p to assemble and 
would block the assembly of Ade4p. This is because there is no 
reason to activate Ade4p, even in the absence of adenine, if the 
upstream enzymes are inactivated or down-regulated. Consistent 
with this prediction, only Prs5p forms structures when yeast are 
shifted to media lacking both glucose and adenine (Figure 6B). 
Thus, the assembly of Prs5p and Ade4p is coordinately regulated 
and the hierarchy of assembly reflects their relative position in the 
de novo purine biosynthetic pathway (Figure 6E).
The assembly of PRPP synthetase is evolutionarily 
conserved
The coordinate regulation of Prs5p and Ade4p assembly raised the 
question of whether the ability of these enzymes to form structures 
is evolutionarily conserved. Previous work on the mammalian ortho-
logue of Ade4p, PPAT, found that it was recruited to purinosomes in 
response to purine deprivation (An et al., 2008). This suggested 
that activation of PPAT/Ade4p via recruitment to an intracellular 
structure might be evolutionarily conserved. However, the unusual 
subunit architecture of yeast PRPP synthetase suggested that 
polymerization might be unique to the yeast enzyme. The active 
forms of yeast PRPP synthetase are assembled from unique combi-
nations of the 5 PRS gene products (Hove-Jensen, 2004). This allows 
the potential down-regulation of enzyme activity by sequestering an 
essential subunit via polymerization. However, mammalian PRPP 
synthetases are homohexameric, suggesting that this type of regu-
lation might not exist in higher eukaryotes (Li et al., 2007). To test 
whether the PRPP synthetase filament formation is evolutionarily 
conserved, we immunostained Drosophila ovaries, rat hippocampal 
neurons, and human primary culture fibroblasts for PRPP synthetase. 
In all three cases, we found that PRPP synthetase forms filaments in 
the nucleus under normal growth conditions (Figure 7, A–C). Thus, 
the ability of PRPP synthetase to form filaments is evolutionarily 
conserved.
DISCUSSION
Regulation of metabolic networks by self-assembling 
enzymes
There have been several proposed roles for metabolic enzymes 
assembling into supramolecular complexes. End-product inhibition 
by CTP is a trigger for bacterial CTP synthetase to polymerize in an 
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inactive state, arguing that the formation of these complexes can be 
used to buffer the amount of free, active enzyme (Barry et al., 2014). 
In contrast, acetyl Co-A carboxylase forms filaments as part of its 
activation mechanism, arguing that polymerization might facilitate 
cooperative activation of the enzyme (Meredith and Lane, 1978; 
Beaty and Lane, 1983b). In addition to playing roles in activation 
and inactivation of single enzymes, multiple enzymes of the 
mammalian de novo purine biosynthetic pathway coassemble into a 
single structure, the purinosome, which argues that these structures 
might also play a role in accelerating pathway flux via substrate 
channeling (An et al., 2008). While these studies have supported a 
variety of regulatory roles for metabolic enzyme structures, it has 
remained unclear whether this type of regulation is just an idiosyn-
cratic feature of particular enzymes or there are rules that determine 
where in a metabolic network this type of regulation is deployed.
Our visual screen of the yeast GFP strain collection identified 
60 metabolic enzymes that are capable of forming structures. In 
contrast to other previous screens of the yeast GFP strain collec-
tion, we assayed multiple growth conditions and measured the 
extent of structure formation in the population of cells. Our analy-
sis revealed that assembly of metabolic enzymes was often associ-
ated with locations within a pathway where either their substrate or 
their product is highly connected with other parts of the metabolic 
network. This selective positioning could be important in times of 
growth and stress, where reorganization of enzymes could pro-
mote and inactivate enzyme activity to ensure coordination of 
metabolites.
This conclusion is supported by our analysis of Prs5p and Ade4p 
assembly in the de novo purine biosynthetic pathway. If enzyme 
polymerization/assembly were a mechanism for controlling pathway 
activity, we would expect the formation of these structures to be 
coordinately regulated—there is no need to activate a downstream 
enzyme if the upstream enzymes have been inactivated. The fact 
that the assembly of Prs5p into an inactive polymer occurs when 
glucose is limiting, while the Ade4p foci form when the pathway is 
activated in response to a lack of adenine, provided a unique 
opportunity to test this mechanism of pathway regulation. Our ob-
servation that when yeast is acutely deprived of both glucose and 
adenine, Prs5p polymerizes, while Ade4p remains dispersed within 
the cytoplasm, argues that these structures are coordinately con-
trolled and that there is a hierarchy to their formation: inactivation of 
upstream steps (Prs5p filament formation) blocks the activation of 
downstream steps (Ade4p foci formation).
This result also has implications for recent studies of the effect of 
nutrient limitation, ATP depletion, and pH on cytoplasmic fluidity 
and crowding. It has been proposed that each of these factors can 
drive the assembly of protein condensate filaments via its effect on 
cell volume, protein solubility, and/or cytoplasmic fluidity (Petrovska 
et al., 2014; Joyner et al., 2016; Munder et al., 2016). The behavior 
of Prs5p and Ade4p, however, suggests that there is not a single 
biophysical signal triggering enzymes to form condensates and/or 
filaments. Most likely, these biophysical signals sensitize the system 
and facilitate metabolic enzyme assembly in response to specific 
nutrient states, such as glucose and/or adenine depletion.
Previous reports have supported the notion that assembly of 
consecutive enzymes in a metabolic pathway acts to facilitate flux 
through a pathway via substrate channeling. However, we found 
little support for substrate channeling from our screen. Consistent 
with the lack of a yeast equivalent of the mammalian purinosome, 
our global analysis did not identify entire pathways composed of 
enzymes that formed structures. This was particularly true in glycoly-
sis, where we found that none of the enzymes that form structures 
act at consecutive steps of the pathway. Instead, the glycolytic 
enzymes that were capable of assembly either generated or con-
sumed highly connected metabolites in the pathway. Given that 
many of the intermediates derived from glycolysis fuel other path-
ways such as amino acid or lipid biosynthesis, the assembly of a 
subset of glycolytic enzymes into these structures may provide a 
mechanism for efficient utilization of carbon sources by gating 
flux through multiple branching pathways. Furthermore, the set of 
glycolytic enzymes that form structures may be adaptive to specific 
stresses, since the enzymes we identified do not substantially 
overlap with those found to be localized to RNA granules in 
response to hypoxic stress (Jin et al., 2017).
Stress granules and filaments as potential sites of metabolic 
enzyme cross-regulation
Interestingly, while we find little evidence for assembly of enzymes 
acting in consecutive steps of a metabolic pathway, we did find 
limited colocalization of enzymes in different pathways in two situa-
tions we examined. First, we found five pairs of metabolic enzyme 
filaments (Supplemental Figure 1) that interacted with each other in 
addition to forming separate filaments. Interestingly, before our 
screen, only two metabolic enzyme filaments were known to interact 
with each other: IMP dehydrogenase and CTP synthetase. The 
lateral interaction between these two enzyme filaments in response 
FIGURE 7: Filament formation of PRPP synthetase is evolutionarily conserved. Conservation of PRPP synthetase into 
filaments observed in Drosophila egg chambers (A), rat neurons (B), and human fibroblasts (C). The insert at the top left 
corner of each image is 3× magnified from the original image. PRPP synthase is stained with anti-PRPS1 (Covance; in 
red), and tubulin is detected with anti–tubulin-FITC (Sigma; in green).
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to specific stresses has been proposed to help balance CTP and 
GTP biosynthesis in mammals (Carcamo et al., 2011; Liu, 2016). 
However, we found that this interaction is not conserved because 
none of the IMP dehydrogenases (Imp2-4p) in yeast form filaments. 
Interestingly, filaments composed of the yeast CTP synthetase, 
Ura7p, do interact with filaments composed of the Prs5p subunit of 
PRPP synthetase. The interaction between filaments composed of 
enzymes that act at the top of purine biosynthesis and the bottom 
of pyrimidine biosynthesis suggests that the regulatory possibilities 
proposed for IMPDH and CTPS in mammals might also occur in 
yeast, but with different sets of enzymes. While the potential regula-
tory interactions between the remaining pairs of interacting 
filaments remains unclear, the results of our screen provide a basis 
for future studies for defining the structural basis for how distinct 
enzyme filaments can interact.
Ironically, the other example of enzyme colocalization that we 
observed was yeast IMP dehydrogenase coassembling with two 
other enzymes that act at the second branch point of the de novo 
purine biosynthetic pathway. Instead of forming autonomous struc-
tures such as Prs5 and Ade4, these three enzymes are recruited into 
stress granules. This observation suggests that recruitment of IMP 
dehydrogenase into enzyme regulatory structures might be a recur-
ring theme in evolution, but that the nature of the structure (filament 
vs. stress granule) may vary from species to species. Additionally, 
the localization of metabolic enzymes in stress granules suggests 
that not all metabolic enzyme structures are composed solely of 
metabolic enzymes and that they could play roles in integrating 
metabolic regulation with the control of other cellular pathways. 
This is consistent with the role of RNA granules in recruiting and 
regulating the activity of particular signaling pathways (Shah et al., 
2014; Zhang et al., 2016). Given that the identity of which glycolytic 
enzymes are recruited into RNA granules varies depending on the 
stress, it is possible that RNA granule recruitment provides a route 
for differentially regulating metabolic pathways in response to trans-
lational, oxidative, and/or nutrient stresses (Jin et al., 2017).
Alternatively, there has been increasing interest in the possibility 
that certain metabolic enzymes can act as RNA-binding proteins to 
regulate gene expression posttranscriptionally. This interest has 
been driven by results from global screens for RNA-binding proteins 
that identified a large number of metabolic enzymes, as well as pre-
vious studies of the TCA cycle enzyme aconitase (Scherrer et al., 
2010; Castello et al., 2012, 2016; Mitchell et al., 2013; Liao et al., 
2016). Aconitase is an Fe–S cluster enzyme; however, when iron limi-
tation leads to failure to form an Fe–S cluster, it is an RNA-binding 
protein that regulates the translation and stability of mRNAs for key 
iron uptake genes, such as transferrin (Haile et al., 1992; Eisenstein, 
2000). While only Imd3p has been identified as a RNA-binding 
protein in global screens, the localization of these three purine bio-
synthetic enzymes in stress granules implies that they could have 
secondary functions similar to those of other moonlighting enzymes 
such as aconitase (Mitchell et al., 2013). Future studies directed at 
identifying the complete set of metabolic enzymes that localize in 
stress granules will help determine whether stress granules act as 
sites for integrating stress response with metabolic activity or 
whether the localization reflects additional moonlighting roles for a 
subset of metabolic enzymes.
Conservation of metabolic enzyme assembly
CTP synthetase filament formation was simultaneously discovered 
in bacteria, Drosophila melanogaster, S. cerevisiae, and humans 
(Ingerson-Mahar et al., 2010; Liu, 2010; Noree et al., 2010; Carcamo 
et al., 2011). This suggested that the ability of metabolic enzymes to 
assemble into structures might be broadly conserved across spe-
cies. However, the fact that the purinosome is not conserved from 
yeast to mammals argued that there may not be a simple one-to-
one correspondence between enzyme structures in different 
species. The results of our screen provide a robust foundation for 
comparing assembly behavior across species. For instance, our 
screen identified 10 metabolic enzymes that form structures within 
mitochondria. These 10 metabolic enzyme structures do not appear 
to be localized in nucleoids or other known mitochondrial struc-
tures, based on their distribution. While the sole purpose of these 
structures could be to regulate enzyme activity, it is also possible 
that these structures could play a role in organizing the numerous 
membrane contacts between mitochondria and other organelles 
(Lackner, 2019). Alternatively, they could play a role in partitioning 
metabolic activity throughout the mitochondrial reticulum—a result 
consistent with our finding that enzyme structures are found in the 
mitochondrial regions with the highest metabolic activity (Figure 2; 
Supplemental Figures 2 and 3). Determining whether these 10 en-
zymes form structures in the mitochondria of higher eukaryotes and/
or bacteria could help address these questions as well as providing 
insights into how metabolic enzyme assembly can be coopted by 
evolution to solve different biological problems.
One example of this approach is evidenced by our discovery that 
the ability of PRPP synthetase to form filaments is conserved from 
yeast to humans. Furthermore, our observation that PRPP synthe-
tase forms filaments in the nuclei of mammalian cells, while in S. 
cerevisiae, the filaments are composed of inactive subunits that 
polymerize in the cytoplasm, argues that assembly might be 
conserved, but the purpose and location of the structure may vary 
greatly between species. Given that many inborn errors in metabo-
lism display tissue-specific phenotypes that are difficult to explain 
in light of the known biochemical function of the enzyme, future 
comparative studies that leverage the results of our screen could 
provide insights into whether enzyme assembly behavior contrib-
utes to the pathophysiology of some of these diseases.
MATERIALS AND METHODS
Yeast strains and media
Yeast strains used in this study are listed in Supplemental Table S9. 
Briefly, all strains were grown at 30°C in 5 ml liquid YPD (2% pep-
tone, 1% yeast extract, 2% dextrose) unless otherwise indicated, 
with shaking for the indicated time points. Strains with GFP-tagged 
proteins were from the yeast GFP collection (Howson et al., 2005).
Yeast GFP collection screen
Cells were fixed by adding 100 µl of 37% wt/vol formaldehyde to 
1 ml of yeast liquid culture and incubated on a rotating platform for 
at least 15 min at room temperature. Cells were then washed once 
with sterile water and resuspended in 1 M sorbitol before counting 
and imaging. Structure formation was quantitated by counting the 
total number of cells and the number of cells with structures from at 
least 250 cells and is reported as the percentage of cells with 
structures.
Construction of yeast strains
Generation of mCherry/mNeonGreen. Plasmids pBS34 (mCherry/
KanMX6) or pBS35 (mCherry/HygromycinB) were used to generate 
mCherry-tagging cassettes via PCR and transformed into the 
appropriate GFP background strain. Plasmid pKT-mNeonGreen-
His3MX6 (gift from the Zid lab, University of California [UC] San 
Diego) was used to generate mNeonGreen-tagging cassettes 
via PCR and transformed into the BY4741 background strain. 
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The positive clones were validated by PCR and fluorescence 
microscopy. In all cases, the primers were designed according to 
established protocols (http://depts.washington.edu/yeastrc/pages/
pBS34.html), except that 10 additional nucleotides were added to 
the homology sequence of the gene of interest to improve the 
efficiency of homologous recombination.
Generation of HA-tagged strains. The 3HA-KanMX6 cassette was 
PCR amplified from pFA6a-3HA-kanMX6 in the same manner as the 
mCherry cassettes and transformed into yeast strain BY4741, using 
the lithium acetate/PEG method (Ito et al., 1983). Positive clones 
were verified by PCR and indirect immunofluorescence.
Construction of Ade4p feedback inhibition–resistant yeasts. The 
full-length ADE4 coding sequence was amplified from genomic 
DNA isolated from yeast strain BY4741 using primers that intro-
duced an SalI site at the start of the gene and an SmaI site at the 
end of the gene. The ADE4 coding sequence was then subcloned 
into pFA6a-GFP-kanMX6 upstream of the GFP cassette. Site di-
rected mutagenesis was then used to introduce the K333Q muta-
tion into ADE4 in the pFA6a-ADE4-GFP-kanMX6 plasmid (primers 
available on request). After the K333Q mutation was verified by 
sequencing, the ade4(K333Q)-GFP-kanMX6 cassette was PCR-am-
plified with primers containing 50 base pairs upstream of the ADE4 
start codon and 50 base pairs downstream of the ADE4 stop 
codon. The PCR product was then transformed into yeast strain 
BY4741 using the lithium acetate/PEG method (Ito et al., 1983). 
Transformants were selected on YPD agar plate containing G418 
(400 µg/ml) and verified by sequencing.
Yeast strains for epitasis studies. Strains from the GFP collection 
(MATa his3∆1 leu2∆0 met15∆0 ura3∆0) were crossed with specific 
strains from the yeast knockout collection (MATα his3∆1 leu2∆0 
lys2∆0 ura3∆0; gift from Maho Niwa, UC San Diego). The crosses 
were plated onto YPD plates and restreaked onto Met-/Lys- dou-
ble-dropout plates to select for diploid cells. Single colonies were 
then inoculated into 2 ml YPD and incubated for 8 h at 30°C. The 
cells were washed and resuspended in 1 ml Spo-UL medium (0.1% 
yeast extract; 1% potassium acetate; 0.05% dextrose; 0.002% leu-
cine; 0.004% uracil) and grown for 5–6 d on a rotator at room tem-
perature. Tetrads were then digested with 200 U/ml zymolase 
(Zymo Research) and microdissected into single cells on YPD 
plates, followed by growth at 30°C for 48 h. Colonies were 
gridded onto YPD plates and grown overnight. The master plate 
was then replica-plated on either G418+ YPD or SC-His dropout 
plates and grown overnight. Each haploid was genotyped by PCR 
or growth on selective media to ensure the presence of the GFP, 
the deletion, and the markers of our standard strain background 
(his3∆1 leu2∆0 met15∆0 ura3∆0).
Mitochondrial staining
For MitoTracker Red staining, GFP-tagged strains were grown to 
either log phase or 1 d in YPD at 30°C with shaking. MitoTracker Red 
(Life Technologies) was added to the culture to a final concentration 
of 0.1 µM and incubated at room temperature on a rotatory plat-
form in the dark for 30 min. Cells were then washed once, resus-
pended in 1 M sorbitol, and imaged immediately.
For TMRE (tetramethylrhodamine, ethyl ester; Sigma Aldrich), 
GFP-tagged strains were grown to either log phase or 1 d in YPD 
at 30°C with shaking. Cells were pelleted and washed in 1X 
phosphate-buffered saline (PBS). Next, TMRE was added to samples 
to a final concentration of 5 nM and incubated at room temperature 
on a rotatory platform in the dark for 15 min. Cells were then washed 
once and resuspended in 1X PBS and imaged immediately.
Fluorescence microscopy and image analysis
Images from screening the Yeast GFP collection, MitoTracker Red, 
and colocalization experiments were acquired using a DeltaVision 
system with an Olympus IX70 microscope, an Olympus PlanApo 
60×/1.40 Oil objective, and SoftWoRx software version 2.5 (Applied 
Precision). Images for mitochondrial staining using the pVTU-mito-
dsRed plasmid and TMRE, as well as RNA granule colocalization, 
were taken using a Zeiss Axiovert 200M fluorescence microscope 
equipped with a CSU-X1 spinning disk (Yokogawa), an iChromeMLE 
laser source (Toptica Photonics), and µManager version 1.4 soft-
ware. For each acquisition, a 2-µm Z-stack was taken with slices at 
0.25-µm intervals using the 40× (or 100× for intensity ratio determi-
nation) objective.
For colocalization experiments, cells were then grown to stages 
where formation of the GFP-tagged structure was greatest and then 
fixed in 4% formaldehyde (with the exception of IMD2::GFP, 
IMD3::GFP, and IMD4::GFP) before imaging. For RNA granule and 
chaperone colocalization experiments, images were taken and then 
analyzed on ImageJ and colocalization was determined by examin-
ing each confocal slice image. Independent experiments were 
repeated at least three times for graphing (mean ± SEM).
Protein extraction and Western blotting
Whole cell extracts were prepared via NaOH extraction according to 
Kushnirov (2000). Briefly, 2.5 OD600 cells were harvested, resus-
pended in 0.1N NaOH, and incubated at room temperature for 
5 min. Following centrifugation, cell pellets were resuspended in 2× 
sample buffer and subsequently boiled for 5 min at 95°C. Cell lysates 
were then resolved by 10% SDS–PAGE. Proteins were transferred to 
a nitrocellulose membrane (GE Amersham) by electroblotting (Owl 
HEP-1; Thermo Scientific). Then the standard protocol for Western 
blot was performed. To detect GFP-tagged proteins, 1:5000 rabbit 
anti-GFP (Torrey Pines Biolabs) was used as a primary antibody 
and 1:10,000 ECL donkey anti-rabbit immunoglobulin G (IgG), 
horseradish peroxidase-linked whole antibody (GE Healthcare UK) 
as a secondary antibody. For internal loading–control detection, 
1:10,000 mouse anti–3-phosphoglycerate kinase (yeast) IgG1 mono-
clonal antibody (Invitrogen) was used as a primary antibody and 
1:2500 ECL sheep anti-mouse IgG, horseradish peroxidase-linked 
whole antibody (GE Healthcare UK) as a secondary antibody.
Media shift experiments
For disassembly experiments, yeast strains were grown in YPD at 
30°C with shaking for the indicated number of days and subse-
quently washed once and resuspended into new media (YPD, YP, 
2% glucose, or water). Cells were then incubated for 30 min at 30°C 
with rocking and immediately imaged. Cells were also taken for 
protein extraction followed by Western blot analysis.
For assembly experiments, yeast strains were grown to log phase 
in SD media, washed once with new media (SD, SD lacking glucose, 
SD lacking adenine, or SD lacking glucose and adenine), and resus-
pended in appropriate media. Cells were incubated for 30 min at 
30°C with rocking and immediately imaged. All experiments were 
independently repeated three times and illustrated as percentages 
of cells with visible structures (mean ± SEM).
Yeast indirect immunofluorescence
Indirect immunofluorescence was performed as previously 
described (Noree et al., 2010).
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Generation of anti-PRPS1 antibody
The full-length coding region of PRPS1 was cloned into pProEx-Htc 
and expressed as an N-terminal 6xHis-tagged fusion protein in BL21 
(DE3) E. coli. Soluble His-PRPS1 was purified using a Ni-nitrilotriace-
tic acid affinity column, eluted with imidazole, and injected into rab-
bits (antiserum production by Covance). The antiserum was purified 
against 6xHis-PRPS1 protein on a CnBr-activated sepharose 4B (GE 
Healthcare) column.
PRPS1 immunostaining
Immunostaining and microscopy for Drosophila egg chambers were 
performed as previously described (Wilhelm et al., 2003). Immuno-
staining and microscopy for rat neurons was performed as previ-
ously described (Noree et al., 2010). For fibroblast staining, primary 
fibroblasts (R. Naviaux, UC San Diego) were plated on coverslips 
and cultured for 5 d at 37°C and 5% CO2 in MEM (Invitrogen) sup-
plemented with 10% fetal bovine serum (Cellgro), 1% l-glutamine 
(Invitrogen), and 1% penicillin streptomycin (Invitrogen). Fibroblasts 
were fixed by incubating in 4% paraformaldehyde in PBS for 20 min. 
The coverslips were then rinsed with 1X PBS followed by two 5-min 
washes in 1X PBS. The cells were incubated for 17 min at room 
temperature in permeabilization solution (PBS with 1% goat serum 
and 0.5% Triton X-100) followed by three 5-min washes in blocking 
solution (PBS and 1% goat serum). The coverslips were incubated 
overnight at 4°C in primary antibody diluted in blocking solution. 
The cells were washed twice for 5 min using blocking solution and 
then incubated for 2 h at room temperature in secondary antibody 
diluted in blocking solution. The secondary antibody was then aspi-
rated to incubate for 10 min in 4′,6-diamidino-2-phenylindole (DAPI) 
diluted in blocking solution and rinsed quickly, followed by three 
5-min washes in blocking solution. This was followed by a quick 
wash in water. The coverslips were mounted using Vectashield (Vec-
tor Laboratories) and imaged using a laser confocal microscope 
(TCS SP5; Leica). The following antibodies were used for immunos-
taining: α-PRPS1 (1:300; this article), α–tubulin-FITC (1:150; Sigma), 
and α-rabbit AlexaFluor 568 (Invitrogen) secondary antibody.
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